Dr. Graham Emslie, who has participated in a number of psychiatric drug trials for children, appeared in a brief interview clip on an Austin TV station’s investigation into SSRI use among children. Emslie was contracted by GlaxoSmithKline as an investigator in a study examining the effects of paroxetine (Paxil) on child/adolescent depression. As such, he was aware that data showed that Paxil was no more effective than a placebo, but (and here’s the killer quote):
I couldn’t talk about it because it was proprietary.
Of note, on his webpage, it is stated that Emslie "is known internationally for his work in the treatment of pediatric depression." Perhaps he should also be known as an academic who is willing to suppress results unfavorable to his corporate sponsors. Of course, Emslie should not be singled out; at least he had the courage to be interviewed. There are many other who have agreed to keep unfavorable data hidden.
No comments:
Post a Comment